Recent progress on the discovery of antiamoebic agents.

Bioorg Med Chem Lett

College of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, South Korea. Electronic address:

Published: November 2016

AI Article Synopsis

  • Entamoeba histolytica is the main protozoan causing amoebiasis, a severe illness second only to malaria.
  • Previous antiamoebic agents based on heterocyclic compounds have been developed, but many only show moderate effectiveness.
  • This digest Letter reviews new findings on antiamoebic agents from 2011 to 2016, focusing on various classes of heterocyclic compounds.

Article Abstract

A large number of protozoans infect humans but Entamoeba histolytica is the only organism responsible for causing amoebiasis, a deadly disease after malaria. Numerous heterocycle-based antiamoebic agents have been previously synthesized as E. histolytica inhibitors and while some of these agents have shown moderate activity, the search for a novel and ideal antiamoebic compound is still ongoing. In this digest Letter, we present the latest data on antiamoebic agents from 2011 to 2016 based on the different classes of heterocyclic agents.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2016.09.040DOI Listing

Publication Analysis

Top Keywords

antiamoebic agents
12
agents
5
progress discovery
4
antiamoebic
4
discovery antiamoebic
4
agents large
4
large number
4
number protozoans
4
protozoans infect
4
infect humans
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!